OpenURL Connection Search

Select item for more details and to access through your institution.

Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis.
Published in:
Vaccines, 2020, v. 8, n. 1, p. 56, doi. 10.3390/vaccines8010056
By:
- Aggarwal, Charu;
- Cohen, Roger B.;
- Morrow, Matthew P.;
- Kraynyak, Kimberly A.;
- Sylvester, Albert J.;
- Cheung, Jocelyn;
- Dickerson, Kelsie;
- Schulten, Veronique;
- Knoblock, Dawson;
- Gillespie, Elisabeth;
- Bauml, Joshua M.;
- Yan, Jian;
- Diehl, Malissa;
- Boyer, Jean;
- Dallas, Michael;
- Kim, J. Joseph;
- Weiner, David B.;
- Skolnik, Jeffrey M.
Publication type:
Article
CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer.
Published in:
Cancer Immunology, Immunotherapy, 2017, v. 66, n. 12, p. 1609, doi. 10.1007/s00262-017-2053-4
By:
- Bengsch, Fee;
- Knoblock, Dawson;
- Liu, Anni;
- McAllister, Florencia;
- Beatty, Gregory
Publication type:
Article
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers.
Published in:
2019
By:
- Tebas, Pablo;
- Kraynyak, Kimberly A;
- Patel, Ami;
- Maslow, Joel N;
- Morrow, Matthew P;
- Sylvester, Albert J;
- Knoblock, Dawson;
- Gillespie, Elisabeth;
- Amante, Dinah;
- Racine, Trina;
- McMullan, Trevor;
- Jeong, Moonsup;
- Roberts, Christine C;
- Park, Young K;
- Boyer, Jean;
- Broderick, Kate E;
- Kobinger, Gary P;
- Bagarazzi, Mark;
- Weiner, David B;
- Sardesai, Niranjan Y
Publication type:
journal article

Found: 3

Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis.

CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer.

Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers.